X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.290
+0.150 (3.62%)
Apr 17, 2026, 4:00 PM EDT - Market closed
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $390.05 million as of April 17, 2026. Its market cap has increased by 885.09% in one year.
Market Cap
390.05M
Enterprise Value
214.33M
1-Year Change
885.09%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $390.05M, an increase of 283.25%. That is a compound annual growth rate of 20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 390.05M | 11.52% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 401.81M |
| Neumora Therapeutics | 391.39M |
| Niagen Bioscience | 388.40M |
| Avalo Therapeutics | 385.49M |
| Greenwich LifeSciences | 384.32M |
| Ovid Therapeutics | 383.76M |
| Nautilus Biotechnology | 383.49M |
| Cabaletta Bio | 382.95M |